|
Volumn 65, Issue 5, 2008, Pages
|
Abuse deterrence focus of upcoming opioid formulations
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DIAMORPHINE;
MORPHINE;
NICOTINIC ACID;
OPIATE;
OXYCODONE;
NARCOTIC ANALGESIC AGENT;
DNA POLYMORPHISM;
DRUG ABUSE;
DRUG DEPENDENCE;
DRUG FORMULATION;
HUMAN;
NOTE;
PRESCRIPTION;
PRIORITY JOURNAL;
CHEMISTRY;
METHODOLOGY;
OPIATE ADDICTION;
PAIN;
PHARMACEUTICS;
ANALGESICS, OPIOID;
CHEMISTRY, PHARMACEUTICAL;
HUMANS;
MORPHINE;
OPIOID-RELATED DISORDERS;
OXYCODONE;
PAIN;
TECHNOLOGY, PHARMACEUTICAL;
|
EID: 40349096417
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news080018 Document Type: Note |
Times cited : (5)
|
References (0)
|